|
|
|
|
|
|
|
Accelerate Diagnosti (AXDX)
|
|
23.35 -1.1 (-4.5%)
|
04-25 16:00
|
|
Open:
|
24.35
|
Pre. Close:
|
24.45
|
|
High:
|
24.475
|
Low:
|
23.25
|
|
Volume:
|
99,860
|
Market Cap:
|
1303M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
24.491 - 24.655
|
24.655 - 24.792
|
|
Low:
|
22.943 - 23.099
|
23.099 - 23.228
|
|
Close:
|
23.122 - 23.375
|
23.375 - 23.584
|
|
|
|
Technical analysis (as of: 2018-04-25 4:24:58 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 28.11 One year: 29.61
|
|
Support:
|
Support1: 22.00 Support2: 18.30
|
|
Resistance:
|
Resistance1:
24.07 Resistance2: 25.35
|
|
Pivot:
|
24.16 
|
|
Moving Averages:
|
MA(5): 24.26 MA(20): 23.79
MA(100): 26.18 MA(250): 25.27
|
|
MACD:
|
MACD(12,26):
-0.08 Signal(12,26,9): -0.16
|
|
%K %D:
|
%K(14,3): 56.59 %D(3): 69.61
|
|
RSI:
|
RSI(14): 41.01
|
|
52-Week:
|
High: 30.45
Low: 16.75 Change(%): -12.7
|
|
Average Vol(K):
|
3-Month: 22604
10-Days 13022
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.AXDX has closed above bottom band by 13.4%. Bollinger Bands are 53.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to AXDX's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-03-23T07:04:53-04:00
Accelerate Diagnostics prices $150M convertible debt offering
2018-03-07T18:35:48-05:00
Daily Insider Ratings Roundup For March 6, 2018: FOLD, RDUS, BW, AXDX, TMUS, GKOS, And BOMN
2018-02-27T08:59:33-05:00
Daily Insider Ratings Round Up 2/22/18
2018-02-26T19:36:39-05:00
T2 Biosystems Might Hit A Home Run In 2018
2018-02-15T21:00:05-05:00
Accelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q4 2017 Results - Earnings Call Transcript
2018-02-15T16:42:08-05:00
Accelerate Diagnostics beats by $0.06, misses on revenue
2017-12-13T08:52:50-05:00
Premarket analyst action - healthcare
2017-11-21T00:17:20-05:00
Daily Insider Ratings Round Up 11/17/17: LXRX, SQBG, BCEI, AXDX, AAT, JOE, HK
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
